Delivery Order SPE2DB22D3016-SPE2DB24FBFE3
Award Date
8/26/24
Potential Completion Date
8/27/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $13,069.24 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has an ultimate completion date of January 9, 2024, is for the delivery of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. This Delivery Order contract is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $17,347.46 Firm Fixed Price delivery order to Amerisourcebergen Drug Corp for the supply of GEMTESA 75 MG TABLET 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 that enables the DLA to procure a comprehensive range of pharmaceutical and medical supplies from Amerisourcebergen to support military treatment programs and facilities worldwide. The contract...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $71,258.34 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of GEMTESA 75 MG TABLET 30S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which serves as a primary vehicle for delivering a comprehensive range of pharmaceutical and medical...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $15,937.28 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide GEMTESA 75 MG TABLET 30S. This contract has an ultimate completion date of June 3, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,178.62 firm fixed-price delivery order is for the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 1, 2023 and was awarded on October 31, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Department of Defense (DoD) Medical Supply Chain (also known as the Defense Logistics Agency (DLA) Troop Support Medical) awarded a $2,230.84 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of GEMTESA 75 MG TABLET 90S. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with the DLA, which serves as the primary vehicle for the company to deliver a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,942.18 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the for-profit pharmaceutical distribution company AmerisourceBergen Corporation. The $5,012.59 contract is for the provision of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a completion date of February 14, 2024. AmerisourceBergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December...
This is a $28,189.69 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GEMTESA 75 MG TABLET 90S, with a period of performance through May 30, 2025. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical, which serves as a global pharmaceutical support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,534.61 firm fixed price delivery order is for the supply of GEMTESA 75 MG TABLET 30S, a prescription medication. The contract has a performance period ending on June 6, 2025 and is not set aside for any special program or business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...